Trials / Terminated
TerminatedNCT02462200
Shave Margins in Breast Conservation Therapy
Shave Margins in Breast Conservation Therapy (SMART): A Randomized Controlled Trial
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- Female
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The investigators propose a randomized controlled superiority trial of standard breast-conserving surgery (BCS) versus BCS with cavity shave margins (CSM). The main objectives of this trial will be to evaluate prospectively the impact of routine standardized CSM on margin status following primary surgery for early stage breast cancer (Stage 0 - II), on post-operative patient satisfaction and cosmetic outcomes, and on general intraoperative time and operative costs. A parallel group format will be implemented to compare this modified surgical therapy - BCS with CSM - with BCS alone, which is the current standard of care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Breast-conserving surgery (BCS) | |
| PROCEDURE | Cavity shave margins (CSM) | |
| BEHAVIORAL | BREAST-Q Questionnaire | |
| DEVICE | 3-D breast imaging | Using a 3-D breast imaging camera Vectra 3-D XT |
| OTHER | Indocyanine green | |
| DEVICE | Intraoperative imaging device | The goggle device is wearable, compact, and battery-operated, and it allows for hands-free operation by the wearer. The goggles provide functional information via a NIR light-emitting diode (LED) integrated within one of the eyepieces, which causes NIR fluorescence excitation of the molecular probes within the surgical field |
| PROCEDURE | Peripheral blood draw | -Time of surgery if coordinator is available |
Timeline
- Start date
- 2016-06-13
- Primary completion
- 2019-11-27
- Completion
- 2019-11-27
- First posted
- 2015-06-03
- Last updated
- 2020-06-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02462200. Inclusion in this directory is not an endorsement.